High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohnʼs disease: A marker for patient classification?-Reference-Cited by-同舟云学术

High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohnʼs disease: A marker for patient classification?

Published:2012-09 Issue:9 Volume:18 Page:1647-1654
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Sandor Kiss Lajos,Papp Maria,Dorottya Lovasz Barbara,Vegh Zsuzsanna,Anna Golovics Petra,Janka Eszter,Varga Eva,Szathmari Miklos,Lakatos Peter Laszlo

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference30 articles.

1. Is the disease course predictable in inflammatory bowel diseases?

2. Laboratory markers in IBD: useful, magic, or unnecessary toys?

3. Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro.

4. Biomarkers to improve diagnostic and prognostic accuracy in systemic infections

5. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of IBD disease activity by Interleukin-6 and serum amyloid A in relation with fecal calprotectin and endoscopic indices;Arab Journal of Gastroenterology;2024-08

2. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

3. C-reactive Protein: An Inflammatory Biomarker and a Predictor of Neurodegenerative Disease in Patients With Inflammatory Bowel Disease?;Cureus;2024-04-25

4. Comparison of Fecal Calprotectin and Myeloperoxidase in Predicting Outcomes in Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2024-02-28

5. Role of Oncostatin M in the prognosis of inflammatory bowel disease: A meta-analysis;World Journal of Gastrointestinal Surgery;2024-01-27